Category

Sin categoría
Spotlight on early career researchers An interview with Sarah Hücker
In this spotlight on early career researchers interview we talk with Sarah Hücker, PostDoc at the Fraunhofer ITEM-R Division Personalized Tumor Therapy in Regensburg, Germany. She develops and automates methods that allow the sequencing of different nucleic acids (DNA, mRNA, miRNA, etc.) of single cells. Could you tell us about your career to date I...
Read More
On 25 April, members of the ADIS Advisory Board gathered online for a consultation on the value of being informed of having Alzheimer’s disease in the stage of Mild Cognitive Impairment. The meeting was facilitated by Project Officers Soraya Moradi-Bachiller and Ana Diaz (Alzheimer Europe), and attended by the neuropsychologist Andrea del Val Guardiola (Fundació...
Read More
Spotlight on early career researchers: an interview with Sophia Krix
In this spotlight on early career researchers interview we talk with Sophia Krix, a PhD student in Computational Life Sciences at the University of Bonn, Germany. She comes from the field of neurobiology and now tackles biomedical questions with the help of artificial intelligence as part of her PhD at the Fraunhofer Institute for Algorithms...
Read More
On 7 March, the members of the European Working Group of People with Dementia (EWGPWD) – who are part of the ADIS Advisory Board – attended an online consultation in the context of the ADIS project. The consultation was facilitated by Soraya Moradi-Bachiller (Project Officer), Dianne Gove (Director for Projects), Ana Diaz (Project Officer), and...
Read More
ADIS 2 AB consultation
On 7 February, Cristina, Kina, García, Ricard and Pilar (members of the ADIS-Advisory Board), and their supporters, held a second online consultation in the context of our Public Involvement activities. As in the first consultation, this meeting focused on the informed consent process in research projects on Alzheimer’s disease. Members of the Advisory Board provided...
Read More
ADIS Consortium photo General Assembly meeting 2023 Tel Aviv Israel From left to right: Christophe Bintener (Alzheimer Europe), Nagy István (SeqOmics), Holger Fröhlich (Fraunhofer SCAI), Tamar Katzir (Tel Aviv University), Raquel Sánchez-Valle (Fundació Clínic per a la Recerca Biomèdica), Uri Nevo (Tel Aviv University), Soraya Moradi Bachiller (Alzheimer Europe), Ella Wilczynsk (Tel Aviv University), Vanessa Lage-Rupprecht (Fraunhofer SCAI), Kuti Baruch (Immunobrain Checkpoint), Sophia Krix (Fraunhofer SCAI) and Eti Yoles (Immunobrain Checkpoint)
From 31 January to 1 February (Tel Aviv, Israel and online), partners from the ADIS project met for their biannual General Assembly meeting. The “Early Diagnosis of Alzheimer’s Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances” – short ADIS project – is a JPND-funded 1.3 million EUR three-year project, coordinated by...
Read More
Advisory Board of the ADIS project meets for its first consultation
On 24 January, Ricard, Pilar, Cristina, Kina and García (members of the ADIS advisory board (ADIS-AB)), and their supporters, met online for their first consultation in the context of Public Involvement activities of the ADIS project. The consultation was hosted by Alzheimer Europe (AE), facilitated by Soraya Moradi-Bachiller (AE Project Officer), and also attended by...
Read More
ADIS stands for “Early Diagnosis of Alzheimer‘s Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances.” The project is funded by the EU Joint Programme for Neurodegenerative Diseases Research (JPND). JPND is the largest global research initiative to address neurodegenerative disease challenges. The ADIS project (start: July 2022) will run for three...
Read More
On 14–15 July, the Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) hosted the kick-off meeting of “ADIS” in Sankt Augustin (Germany). ADIS stands for “Early Diagnosis of Alzheimer‘s Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances”. The project is funded through the EU Joint Programme – Neurodegenerative Disease Research (JPND)....
Read More
Biomarkers and algorithms are to enable minimally invasive and cost-effective early diagnosis of Alzheimer‘s disease Alzheimer‘s disease and related dementias are heterogeneous, multifactorial diseases in which several etiopathogenic mechanisms lead to neuronal cell death and loss of cognitive function.  The disease is believed to begin decades before diagnosis, posing a significant treatment challenge. Therefore, the...
Read More